Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia

Area of Science:

• Hematology
• Genomics
• Molecular Biology

Background:

• Chronic lymphocytic leukemia (CLL) exhibits significant clinical and biological heterogeneity.
• Next-generation sequencing has advanced understanding of CLL pathogenesis but often uses bulk analysis.
• Single-cell technologies provide unprecedented resolution for studying complex diseases like CLL.

Purpose of the Study:

• To review single-cell sequencing technologies applied to chronic lymphocytic leukemia (CLL).
• To discuss their utility in understanding CLL onset, progression, and response to therapy.
• To explore future directions and limitations in single-cell analysis for CLL.

Main Methods:

• Single-cell RNA sequencing (scRNA-seq) for transcriptomic profiling.
• Single-cell immunogenetic profiling of B and T cell receptors.
• Single-cell epigenomic (methylation, chromatin accessibility) and genomic (CNV, SNV) analyses.
• Antibody-based approaches for protein expression profiling.

Main Results:

• Single-cell methods enable detailed mapping of leukemic and microenvironment cells in CLL.
• These technologies reveal tumor heterogeneity and clonal evolution dynamics.
• Application to treatment response, particularly with targeted therapies, is a key area of study.

Conclusions:

• Single-cell technologies are revolutionizing the study of CLL, offering high-resolution insights.
• Integrative multi-omics analysis holds promise for a comprehensive understanding of CLL.
• Addressing technical and bioinformatic challenges is crucial for advancing CLL research.